BBGBloomberg·1hHealth
score-0.30
RevMed’s Rasonque Wins US Approval as a Breakthrough Daily Pill for Advanced Pancreatic Cancer
Original
RevMed’s Pancreatic Cancer Pill Priced Above $475K per Year
“Contrasts the life-saving medical breakthrough with the prohibitive $475K cost, creating a tone of economic concern.”